Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT01624220What this trial is testingA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyWho this might be right forSpinal Tumor M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT03033576What this trial is testingTesting Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown Primary+3 more National Cancer Institute (NCI) 94
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT02966509What this trial is testingEngagement of Patients With Advanced CancerWho this might be right forEnd of LifeAdvanced CancerLung Neoplasm+11 more Stanford University 213
Not applicableActive Not RecruitingNCT06863870What this trial is testingAssessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous MelanomaWho this might be right forMelanoma Neoplasms IRCCS Azienda Ospedaliero-Universitaria di Bologna 35
Not applicableLooking for participantsNCT07524114What this trial is testingStudy of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)Who this might be right forBreast CancerLung CancerMelanoma+7 more University Health Network, Toronto 7,000
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00423254What this trial is testingSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Who this might be right forOvarianMelanomaRenal+20 more Mannkind Corporation 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT04133948What this trial is testingMulticenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary MelanomaWho this might be right forMalignant Melanoma Stage III The Netherlands Cancer Institute 44
Large-scale testing (Phase 3)Active Not RecruitingNCT01274338What this trial is testingIpilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryWho this might be right forMelanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more National Cancer Institute (NCI) 1,673
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04462406What this trial is testingUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop TrialWho this might be right forAdvanced MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+8 more ECOG-ACRIN Cancer Research Group 150
Not applicableLooking for participantsNCT03740503What this trial is testingGenomic Investigation of Unusual RespondersWho this might be right forCancerBreast CancerNon-small Cell Lung Cancer+8 more University Health Network, Toronto 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625What this trial is testingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT02129075What this trial is testingA Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV MelanomaWho this might be right forCutaneous MelanomaMelanomaMelanoma of Unknown Primary+9 more National Cancer Institute (NCI) 60
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72